Skip to content
healthcare.dev

Mirabegron

NDC 70710-1159, Mirabegron, tablet, extended release, from Zydus Pharmaceuticals (USA) Inc..

Product NDC
70710-1159
Status
Listed
Labeler
Zydus Pharmaceuticals (USA) Inc.
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA209488
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70710-1159 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • MIRABEGRON25 mg/1

Pharmacologic classes

Adrenergic beta3-Agonists [MoA]; Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]; beta3-Adrenergic Agonist [EPC]

Package NDCNDC-11Package
70710-1159-170710115901100 TABLET, EXTENDED RELEASE in 1 BOTTLE (70710-1159-1)
70710-1159-37071011590330 TABLET, EXTENDED RELEASE in 1 BOTTLE (70710-1159-3)
70710-1159-97071011590990 TABLET, EXTENDED RELEASE in 1 BOTTLE (70710-1159-9)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/2e40eb74-3b2a-47f7-bf31-fe27484f9bd2
  • NADAC price for package 70710115903

    GET /v1/drugs/nadac/70710115903
  • NADAC price for package 70710115909

    GET /v1/drugs/nadac/70710115909

Use it

Look up 70710-1159 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70710-1159 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70710-1159. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.